News
Welcome to visit us at CPHI Shanghai China booth No.: W1E08 from June 20th to 22th. 2018 17-11-03
Warmly celebrate that Zhejiang Chiral has successfully passed US FDA five days inspection (from OCT.09 to OCT.13.2017) and perfectly resulted with no 483 deficiency, Which is the fourth time approved 17-10-14
Congratulations to our company received GMP certificates for METHYLDOPA on AUGUST .8th of 2017 from CFDA. NO.: ZJ20170051 17-08-11
Congratulations to our company received AUSTRALIA TGA approval letter on Aug.4,2017, which is the second inspection approval for our products (Gabapentin, Carbidopa, Methyldopa). 17-08-07
Welcome to visit us at CPHI Frankfurt Germany booth No.: Hall 8.0 R40 from Oct. 24th to 26th. 2017 17-04-08
Welcome to visit us at CPHI Shanghai China booth No.: E1K16 from June 20th to 22th. 2017. 17-04-08
Congratulations to our company received US FDA approval letter on Mar.28,2017, which is the third inspection approval for our products (Gabapentin, Etodolac, Carbidopa, Methyldopa). 17-04-08
Welcome to visit us at CPHI Barcelona Spain booth No.:6F82 from 4th to 6th.OCT.2016 16-01-26
Welcome to visit us at CPHI Shanghai booth No.:W4B36 from 21th to 23th.JUNE,2016 15-11-11
Please visit us at Stand No W4B07 at CPHI SHANGHAI ,China , from 24th to 26th.JUNE,2015. 14-09-28
CMC Acquired Actavis (Foshan) . 14-06-19
Please visit us at Stand No W4B07 at CPHI Shanghai , from 26th to 28th.JUN,2014. 14-06-19
CMC obtained GMP certificates for ETODOLAC on AUGUST .15th of 2013 from SFDA. NO.: ZJ20130103. 14-06-19
Congratulations to our company got FDA second inspection approval for our gbapentin, carbidopa ,Etodolac ,methyldopa on JAN.25--29,2013. 14-06-19
Congratulations to our company Our product, Gabapentin, received Gabapentin EU GMP certificate ,the certificate NO.:VTV/101012/3GMP-CHI in OCT.10,2012. 14-06-19